PAROMOMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Paromomycin Sulfate patents expire, and when can generic versions of Paromomycin Sulfate launch?
Paromomycin Sulfate is a drug marketed by Heritage Pharms and Sun Pharm Inds Inc and is included in two NDAs.
The generic ingredient in PAROMOMYCIN SULFATE is paromomycin sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the paromomycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paromomycin Sulfate
A generic version of PAROMOMYCIN SULFATE was approved as paromomycin sulfate by HERITAGE PHARMS on December 14th, 2007.
Summary for PAROMOMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Clinical Trials: | 9 |
| Patent Applications: | 2,074 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PAROMOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for PAROMOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Gondar | Phase 3 |
| Makerere University | Phase 3 |
| The Netherlands Cancer Institute | Phase 3 |
Pharmacology for PAROMOMYCIN SULFATE
| Drug Class | Antiprotozoal |
Medical Subject Heading (MeSH) Categories for PAROMOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for PAROMOMYCIN SULFATE
US Patents and Regulatory Information for PAROMOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heritage Pharms | PAROMOMYCIN SULFATE | paromomycin sulfate | CAPSULE;ORAL | 065173-001 | Dec 14, 2007 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Inds Inc | PAROMOMYCIN SULFATE | paromomycin sulfate | CAPSULE;ORAL | 064171-001 | Jun 30, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
